Premium
Inhibition of CYP2D6 with low dose (5 mg) paroxetine in patients with high 10‐hydroxynortriptyline serum levels – a review of routine practice
Author(s) -
Jessurun Naomi,
Puijenbroek Eugène P.,
Otten Leila S.,
Mikes Oe,
Vermeulen Windsant Annemieke,
Marum Rob J.,
Grootens Koen,
Derijks Hieronymus J.
Publication year - 2017
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.13201
Subject(s) - nortriptyline , paroxetine , cyp2d6 , pharmacokinetics , pharmacology , anticholinergic , medicine , antidepressant , amitriptyline , cytochrome p450 , metabolism , hippocampus